AVGO Beat and Raise? Plus, Demmert's Stock Picks: ISRG, BYDDY
James Demmert drops by the NYSE set with a couple of stocks to watch: Intuitive Surgical (ISRG) and BYD (BYDDY). He says both are plays that avoid a potential U.S. slowdown.
Fiscal Year: January - December
Intuitive Surgical, Inc. (ISRG), listed on the NASDAQ, has a market capitalization of $171.71B. As of Jun 05, 2025, the stock is trading at $562.55 per share, offering investors a clear view of its current market value. Intuitive Surgical, Inc. is a prominent player in the industry sector, attracting both institutional and retail investors due to its performance and potential.
With a P/E ratio of 82.36, investors can assess the stock's valuation in comparison to its earnings. A P/E ratio is a crucial indicator for value investors, showing whether the stock is over or undervalued relative to its current earnings. Intuitive Surgical, Inc. also offers a dividend yield of N/A , making it an attractive option for income-focused investors who seek regular dividends.
Our Discounted Cash Flow (DCF) analysis reveals that Intuitive Surgical, Inc. (ISRG) may be overvalued compared to its intrinsic worth. However, to see the exact DCF fair value, please Login or Upgrade for access.
The proprietary SS Score for Intuitive Surgical, Inc. is a unique metric that analyzes the company's financial health and growth potential. The score takes into account critical factors such as revenue growth, net income, free cash flow (FCF) compound annual growth rate (CAGR), the trend of shares outstanding, and the debt-to-FCF ratio. This helps investors to make a more informed decision, as an undervalued stock might still have poor financial fundamentals.
To view the detailed SS Score for Intuitive Surgical, Inc., Login or Upgrade for access.
The Price to Free Cash Flow (P/FCF) ratio for Intuitive Surgical, Inc. is 115.38, offering insights into how much investors are paying for the company's free cash flow. A lower P/FCF ratio typically suggests that the stock is undervalued, while a higher ratio may indicate overvaluation.
In summary, Intuitive Surgical, Inc. (ISRG) has shown consistent financial performance, as illustrated by the financial charts above, which track its revenue growth, net income, free cash flow, and shares outstanding over the past several years. These metrics provide investors with key insights into the company's past and projected future performance. Investors should use the SS Score alongside the DCF Fair Value to make better-informed decisions about whether to buy or hold the stock.
*This analysis is for informational purposes only and does not constitute investment advice. Always read the company's 10-K filings and do your own research before making any investment decisions.
Whether Intuitive Surgical, Inc. (ISRG) is a good stock to buy depends on various factors, including its financial health, market conditions, and your investment strategy. Our analysis indicates that the stock may be overvalued compared to its intrinsic value. However, it is important to assess the SS Score and review the company's fundamentals before making any investment decisions.
The fair value of Intuitive Surgical, Inc. (ISRG) is determined through our Discounted Cash Flow (DCF) analysis. This value represents the intrinsic worth of the stock based on its expected future cash flows. To view the specific fair value, consider subscribing to our service for complete access.
The SS Score is a proprietary financial quality metric that assesses factors such as revenue growth, net income, free cash flow growth, and debt levels. It helps investors evaluate the overall financial health of Intuitive Surgical, Inc.. To access the full SS Score, consider upgrading your subscription.
Intuitive Surgical, Inc. is a significant player in the industry sector, with a market capitalization of $171.71B and a competitive P/E ratio of 82.36. Investors should compare these metrics with industry peers to gauge whether Intuitive Surgical, Inc. is outperforming or underperforming within its sector.
James Demmert drops by the NYSE set with a couple of stocks to watch: Intuitive Surgical (ISRG) and BYD (BYDDY). He says both are plays that avoid a potential U.S. slowdown.
Moderna shares are seeing a boost on Monday after the US Food and Drug Administration (FDA) gave the pharmaceutical giant limited approval for its lower-dose COVID-19 vaccine. Morgan Stanley Investmen...
Intuitive Surgical's deep R&D investment and da Vinci 5 platform create a powerful innovation moat and embed the company further into surgical workflows. Recurring revenue from a growing installed bas...
Intuitive Surgical remains a dominant leader in robotic surgery with strong recurring revenues, high switching costs, and robust financial health. Business fundamentals are excellent, with resilient p...
Intuitive Surgical's share price has rebounded after a sharp drop, driven by strong Q1 2025 results and easing tariff concerns, with further upside expected. As the dominant leader in robotic surgery,...
Industrial robots have been around for decades. They're often used on manufacturing lines, where they perform automated tasks.
President Dave Rosa promoted to CEO Current CEO Gary Guthart to become executive chair of Intuitive's board Current Board Chair Craig Barratt to become lead independent director
Stephanie Link, CIO at Hightower, joins CNBC's "Halftime Report" to detail her latest portfolio moves.
In April, Seeking Alpha welcomed 20 new analysts. This article introduces them and showcases some of their top picks. Top picks include Palantir, Arch Capital Group, and Utah Medical Products, emphasi...
SUNNYVALE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that th...
Initiated positions in Waters Corporation, Penumbra, McKesson, Masimo, and added to UnitedHealth Group due to strong market positions and growth potential. Waters Corporation's growth driven by biopha...
Boston Scientific's shares rose due to strong market growth, innovative products like pulsed field ablation, and disciplined cost management, driving double-digit EPS growth. Vertex Pharmaceuticals sa...
Stephanie Link, CIO at Hightower, joins CNBC's "Halftime Report" to detail her latest buy of Intuitive Surgical
Intuitive Surgical's Q1 2025 earnings showed mixed results, with revenue and EPS beating expectations, but gross margins impacted by tariffs and a lower-margin product mix. Procedure volume growth was...
Intuitive Surgical Inc ISRG reported first-quarter 2025 revenue of $2.25 billion, beating analyst estimates of $2.19 billion.
Intuitive Surgical Inc ISRG reported better-than-expected first-quarter financial results Tuesday after the bell.
Surgical robots firm Intuitive Surgical said exports to and imports from China are subject to high tariffs. Shares are rising Wednesday on hopes the trade war will de-escalate.
Intuitive Surgical, Inc. (NASDAQ:ISRG) Q1 2025 Earnings Conference Call April 22, 2025 4:30 AM ET Company Participants Dan Connally - Head of IR Gary Guthart - CEO David Rosa - President Jamie Samath...
Intuitive Surgical raised concerns on Tuesday about the potential impact of tariffs on its annual results, despite exceeding Wall Street's first-quarter profit and revenue estimates.
SUNNYVALE, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today...
The Investment Committee give you their top stocks to watch for the second half.
Intuitive Surgical Inc ISRG will report its first-quarter earnings after the market closes on Tuesday. Wall Street expects earnings per share of $1.72 and revenue of $2.19 billion for the quarter.
Studies show robotic-assisted procedures enable increased access to minimally invasive care Studies show robotic-assisted procedures enable increased access to minimally invasive care
Intuitive's SureForm 45 stapler available for thoracic, colorectal, and urology procedures Intuitive's SureForm 45 stapler available for thoracic, colorectal, and urology procedures
SUNNYVALE, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced the publication of two...